These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 150943)

  • 1. Pharmacologic disposition of chlorozotocin in mice.
    Mhatre RM; Green D; Panasci LC; Woolley PV; Schein PS
    Cancer Treat Rep; 1978 Aug; 62(8):1145-51. PubMed ID: 150943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.
    Fox PA; Panasci LC; Schein PS
    Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of the carcinostatic agent 1-(2-chloroethyl)-3-[1'-(5'-p-nitrobenzoyl-2',3'-isopropylidene)-alpha,beta-d-ribofuranosyl]-1-nitrosourea in animals.
    Godenèche D; Madelmont JC; Moreau MF; Montoloy D; Plagne R
    Cancer Res; 1980 Sep; 40(9):3351-6. PubMed ID: 7427947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
    Panasci LC; Green D; Schein PS
    J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial of chlorozotocin: attempted amelioration of myelotoxicity by glucose administration.
    Panasci L; Comis R; Ginsberg S; Kohn L; Fitzpatrick A; Rubert M; Scalzo T
    Cancer Treat Rep; 1981; 65(7-8):647-50. PubMed ID: 6454483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE; Green D; Schein PS
    Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose.
    Nagourney RA; Fox P; Schein PS
    Cancer Res; 1978 Jan; 38(1):65-8. PubMed ID: 145314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake and decomposition of chlorozotocin in L5178Y lymphoblasts in vitro.
    Lam HY; Talgoy MM; Goldenberg GJ
    Cancer Res; 1980 Nov; 40(11):3950-5. PubMed ID: 6451281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
    Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
    Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity.
    Anderson T; McMenamin MG; Schein PS
    Cancer Res; 1975 Mar; 35(3):761-5. PubMed ID: 123170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological disposition of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in mice.
    Rahman A; Luc PV; Schein PS; Woolley PV
    Cancer Res; 1984 Jan; 44(1):149-53. PubMed ID: 6690033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution, excretion, and metabolism of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea (ACNU) in rats and mice after iv administration.
    Tanaka M; Nishigaki T; Nakajima E; Totsuka S; Nakamura K
    Cancer Treat Rep; 1980; 64(4-5):575-80. PubMed ID: 6933003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and biochemical properties of the 2-hydroxyl metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Heal JM; Fox PA; Doukas D; Schein PS
    Cancer Res; 1978 Apr; 38(4):1070-4. PubMed ID: 147730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The murine disposition and pharmacokinetics of the antineoplastic agent, diaziquone (NSC 182986).
    Spiegel JF; Egorin MJ; Collins JM; Lerner BD; Bachur NR
    Drug Metab Dispos; 1983; 11(1):41-6. PubMed ID: 6132794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repair of DNA alkylation induced in L1210 leukemia and murine bone marrow by three chloroethylnitrosoureas.
    Ahlgren JD; Green DC; Tew KD; Schein PS
    Cancer Res; 1982 Jul; 42(7):2605-8. PubMed ID: 6211225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorozotocin, an anti-tumour agent lacking bone marrow toxicity at therapeutic doses: effects on lymphocyte subpopulations in mice.
    Fisher RI; Mandell GL; Bostick F; McMenamin MG; Anderson T
    Clin Exp Immunol; 1980 Feb; 39(2):416-25. PubMed ID: 6446427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of chlorozotocin in rats and dogs.
    Plowman J; Dingell JV; Adamson RH
    Cancer Treat Rep; 1978 Jan; 62(1):31-44. PubMed ID: 146566
    [No Abstract]   [Full Text] [Related]  

  • 19. Distribution of clomesone in mice.
    Noker PE; Hill DL
    Cancer Treat Rep; 1987 Dec; 71(12):1135-40. PubMed ID: 2825990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and molecular mechanisms of the bone marrow sparing effects of the glucose chloroethylnitrosourea chlorozotocin.
    Byrne P; Tew K; Jemionek J; MacVittie T; Erickson L; Schein P
    Blood; 1984 Apr; 63(4):759-67. PubMed ID: 6322885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.